The Implications of Suboptimal Treatment Outcomes with Disease-Modifying Drugs in Employees with Multiple Sclerosis Jul 7, 2020
The Implications of Suboptimal Treatment Outcomes with Disease-Modifying Drugs in Employees with Multiple Sclerosis Jul 7, 2020
Severity of Illness Among Persons with Multiple Sclerosis: An Analysis of Cost Quintiles. Mar 1, 2020
